2014
DOI: 10.14336/ad.2014.0500238
|View full text |Cite
|
Sign up to set email alerts
|

Metabolic Disturbances in Diseases with Neurological Involvement

Abstract: Degeneration of specific neuronal populations and progressive nervous system dysfunction characterize neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. These findings are also reported in inherited diseases such as phenylketonuria and glutaric aciduria type I. The involvement of mitochondrial dysfunction in these diseases was reported, elicited by genetic alterations, exogenous toxins or buildup of toxic metabolites. In this review we shall discuss some metabolic alterations re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
35
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(36 citation statements)
references
References 204 publications
1
35
0
Order By: Relevance
“…Intriguingly, cell non-autonomous effects such as metabolic decline have been observed in these diseases 47 . Therefore, understanding the cell non-autonomous aspects of mitochondrial stress response may allow future control of this protective response, which will have therapeutic potential in the treatment of the symptoms of mitochondrial disorders and neurodegenerative diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Intriguingly, cell non-autonomous effects such as metabolic decline have been observed in these diseases 47 . Therefore, understanding the cell non-autonomous aspects of mitochondrial stress response may allow future control of this protective response, which will have therapeutic potential in the treatment of the symptoms of mitochondrial disorders and neurodegenerative diseases.…”
Section: Discussionmentioning
confidence: 99%
“…The extreme metabolic dysfunction observed in HD patients is far from unique, however. Deleterious changes in metabolism have been reported in a range of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (Cai et al, 2012; Duarte et al, 2014). With neurodegenerative disease, mitochondrial dysfunction in particular manifests across a variety of parameters that include a decline in energy production, impaired tricarboxylic acid cycle activity, decreased electron chain function, and aberrant mitochondrial dynamics (Jenkins et al, 1993; Mochel et al, 2011; Podolsky et al, 1972).…”
Section: Introductionmentioning
confidence: 99%
“…An important consequence of mitochondria stress caused by proteotoxicity is the global alteration of transcription networks associated not only with the regulation of protective chaperones and enzymes (the mitochondrial unfolded protein response, or UPR mt ), but also with metabolism (Cai et al, 2012; Duarte et al, 2014; Nargund et al, 2015). Recent evidence suggests that the transcription factor ATFS-1 is not only capable of upregulating mitochondrial chaperones, proteases, and antioxidant enzymes, but also regulates a large number of genes required for oxidative phosphorylation and glycolysis (Nargund et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…These last mutations accumulate in post-mitotic cells with age and amplify the biochemical effects of the former two classes. Accumulation of somatic mtDNA mutations has been shown to be an important factor in the development of PD and Alzheimer's disease (AD) as well as in aging [27]. The role of mtDNA in PD is supported by the analysis of cybrid cells, generated by the fusion of platelets (from control or patient) as mitochondria donor with recipient cells deprived of mitochondria.…”
Section: Introductionmentioning
confidence: 99%